Výsledky vyhledávání

Feasibility and preliminary efficacy of acupuncture for angina in an underserved diverse population

Autor: Joan Briller, Hui Yan Cai, Glorieuse Uwizeye, Lauren Rountree, Debra Hoppensteadt, Adhir Shroff, Holli A. DeVon, Amer Ardati, Judith M. Schlaeger

Publikováno v: Acupuncture in medicine : journal of the British Medical Acupuncture Society, vol 40, iss 2
Acupunct Med

Purpose: Stable angina is ischemic chest pain on exertion or with emotional stress. Despite guideline-directed therapy, up to 30% of patients have suboptimal pain relief. The aims of this study were to: (1) determine the feasibility and acceptability

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ecae0c05b9a5e76adb2df366ba5e67c
https://escholarship.org/uc/item/60g8d7gp

Zobrazit plný text záznamu

Measure Twice, Cut Once: Adjunctive Physiology and Imaging in Left Main PCI

Autor: Owais Abdul-Kafi, Megan Toole, Monica Montes-Rivera, Adhir Shroff, Amer Ardati

Publikováno v: Current Cardiovascular Imaging Reports. 14

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ee07dab7fbbaae96a554b1dc440b4ab
https://doi.org/10.1007/s12410-021-09562-6

Zobrazit plný text záznamu

Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome

Autor: Daniel R. Touchette, Amer Ardati, Larisa H. Cavallari, Robert J. DiDomenico, Kibum Kim

Publikováno v: Cardiovascular Drugs and Therapy. 33:533-546

Perform a cost-effectiveness analysis comparing strategies for selecting P2Y12 inhibitors in acute coronary syndrome (ACS). Six strategies for selection of P2Y12 inhibitors in ACS were compared from the US healthcare system perspective: (1) clopidogr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca78303efa6d8cc659244ff90de1e48b
https://doi.org/10.1007/s10557-019-06896-8

Zobrazit plný text záznamu

The Burden of Coronary Artery Disease in Chronic Kidney Disease

Autor: Sylvia Marie R. Biso, Amer Ardati

Publikováno v: Kidney Disease in the Cardiac Catheterization Laboratory ISBN: 9783030454135

Cardiovascular disease (CVD) is the leading cause of death in the general US population and in those with chronic kidney disease (CKD). In patients with CKD, cardiovascular death is more common than progression to end-stage kidney disease. The preval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::58d93abc0ce18a5fce3097965a30f3f8
https://doi.org/10.1007/978-3-030-45414-2_1

Zobrazit plný text záznamu

What Happened to Me while I Was in the Hospital? Challenges and Opportunities for Generating Patient-Friendly Hospitalization Summaries

Autor: Matt Baumann, Andrew D. Boyd, Betty Welland, Richard Cameron, Jose D. Flores, Carolyn Dickens, Barbara Di Eugenio, Amer Ardati, Pamela Martyn-Nemeth, Sabita Acharya, Karen Dunn Lopez

Publikováno v: J Healthc Inform Res

Comprehending medical information is a challenging task, especially for people who have not received formal medical education. When patients are discharged from the hospital, they are provided with lengthy medical documents that contain intricate ter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6ae756eb955db419f2cbb7173a5ae8
https://doi.org/10.1007/s41666-018-0036-7

Zobrazit plný text záznamu

Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome

Autor: Kibum Kim, Amer Ardati, Todd A. Lee, Daniel R. Touchette, Robert J. DiDomenico, Surrey M. Walton

Publikováno v: Journal of Managed Care & Specialty Pharmacy. 24:800-812

In patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), newer antiplatelet agents prasugrel and ticagrelor have lower rates of cardiovascular events when compared with clopidogrel. However, it is unclear

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02bb05f139fe403b134c1faeed946e81
https://doi.org/10.18553/jmcp.2018.24.8.800

Zobrazit plný text záznamu

Effects of staged versus ad hoc percutaneous coronary interventions on renal function—Is there a benefit to staging?

Autor: Janani Rangaswami, Edgar V. Lerma, Amer Ardati, Abel Romero-Corral, Mahek Shah, David S. Wheeler, Kene Mezue, Christian Witzke, Obiora Maludum, Deepakraj Gajanana, Chitra Punjabi

Publikováno v: Cardiovascular Revascularization Medicine. 18:344-348

Aim The purpose of this study is to determine whether adhoc (same session) percutaneous coronary intervention, and staged (multiple session) percutaneous coronary intervention (PCI) have different renal outcomes. Methods and Results This is a retrosp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6c129276caa99ebddcdb69e50b372f
https://doi.org/10.1016/j.carrev.2017.02.017

Zobrazit plný text záznamu

Stent selection among patients with chronic kidney disease: Results from the NCDR CathPCI Registry

Autor: Daniel A. Feldman, Adhir Shroff, Jeptha P. Curtis, Amer Ardati, Karl E. Minges, Haikun Bao

Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 96(6)

OBJECTIVES This study sought to define contemporary rates of drug eluting stent (DES) usage in patients with chronic kidney disease (CKD). BACKGROUND Among patients with CKD undergoing percutaneous coronary interventions (PCIs), outcomes are superior

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b871d16e718b3d62e12937af4e2f4e4
https://pubmed.ncbi.nlm.nih.gov/31909543

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání